Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts.
AuteursId Boufker H, Lagneaux L, Najar M, Piccart M, Ghanem G, Body JJ, Journé F
Lessons Learnt From Running a Transition-Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience.
AuteursColizzi M, Basaldella M, Candolo A, Garzitto M, Palermo A, Scipioni C, Tavian G, Balestrieri M, Bortoletto R, Comacchio C
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.
AuteursMetzger Filho O, Cardoso F, Poncet C, Desmedt C, Linn S, Wesseling J, Hilbers F, Delaloge S, Pierga JY, Brain E, Vrijaldenhoven S, Neijenhuis PA, Rutgers EJT, Piccart M, van 't Veer LJ, Viale G
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.
AuteursCremer A, Mansour A, Lobaton T, Bossuyt P, Rahier J, Baert F, Dewit O, Macken E, Vijverman A, Van Hootegem P, Mana F, Willandt B, Humblet E, D'Heygere F, Verreth A, El Nawar A, Coenegrachts J, Dewit S, De Coninck S, Schoofs N, Delen S, Dutre J, Thienpont C, Vanden Branden S, Staessen D, Croonen C, Vieujean S, Franchimont D
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study.
AuteursMaisonobe L, Korganow AS, Berti A, Deroux A, Dupin N, Aractingi S, Emmi G, Vandergheynst F, Fabre M, Kluger N, Roux M, Abisror N, Benyamine A, Cassone G, Chasset F, Doutre MS, Foucher A, Freguin C, Gobert D, Gombeir Y, Hernandez-Rodriguez J, Legouellec N, Pinault AL, Titeca D, Jachiet M, Terrier B
